AMRYT PHARMA PLC - SPNR ADR (AMYT)
US03217L1061 - ADR
| MRQ (2021-9-30) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | 1.36M | 24.62M | |||
| Cash Equivalents | 123.18M | 118.80M | 67.23M | N/A | N/A | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 52.79M | 43.19M | 35.50M | 5.93M | 3.80M | |||
| Inventories | 100.84M | 40.99M | 58.00M | 2.14M | 1.33M | |||
| Other Current Assets | N/A | N/A | N/A | 9.86M | 2.69M | |||
| Total Current Assets | 276.81M | 202.97M | 160.73M | 19.29M | 32.44M | |||
| Non-Current Assets | ||||||||
| PPE Net | 8.40M | 7.57M | 3.04M | 1.10M | 1.43M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Goodwill | N/A | 19.13M | 19.13M | 0.00 | N/A | |||
| Intangibles | 488.73M | 305.37M | 342.33M | 60.30M | 64.84M | |||
| Other Non-Current Assets | 1.65M | 1.54M | 1.87M | 149.00K | N/A | |||
| Total Non-Current Assets | 578.65M | 333.62M | 366.37M | 61.54M | 66.27M | |||
| TOTAL ASSETS | 855.46M | 536.59M | 527.10M | 80.83M | 98.71M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | N/A | N/A | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 1.53M | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | N/A | N/A | N/A | 6.70M | 6.29M | |||
| Accounts Payable | N/A | N/A | N/A | 5.34M | 5.79M | |||
| Other Current Liabilities | 28.00M | 10.94M | 23.88M | 0.00 | N/A | |||
| Total Current Liabilities | 153.84M | 101.17M | 102.23M | 12.04M | 12.08M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 200.60M | 188.39M | 178.47M | 19.01M | 13.07M | |||
| Deferred Taxes/Income | 37.00M | 6.61M | 7.15M | 6.16M | 6.64M | |||
| Other Non-Current Liabilities | 158.00M | 174.27M | 107.42M | 47.32M | 39.96M | |||
| Total Non-Current Liabilities | 395.60M | 369.27M | 293.04M | 72.49M | 59.66M | |||
| TOTAL LIABILITIES | 549.44M | 470.45M | 395.26M | 84.53M | 71.74M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -60.12M | 883.00K | 117.49M | -97.08M | -69.81M | |||
| Additional Paid In Capital | 310.78M | 51.41M | 2.42M | 68.23M | 70.66M | |||
| Common Shares | 25.26M | 13.85M | 11.92M | 25.20M | 26.10M | |||
| Treasury Stock | -7.42M | N/A | N/A | 0.00 | N/A | |||
| Other Shareholders' Equity | 37.52M | N/A | N/A | -51.00K | 27.11K | |||
| Shares Outstanding | 316.90M | 178.80M | 154.50M | 45.80M | 45.80M | |||
| Tangible Book Value per Share | -0.83 | -1.44 | -1.49 | -1.40 | -0.83 | |||
| Total Shareholders' Equity | 306.02M | 66.14M | 131.83M | -3.70M | 26.97M | |||
| TOTAL LIABILITIES AND EQUITY | 855.46M | 536.59M | 527.10M | 80.83M | 98.71M | |||
| Statistics | ||||||||
| Debt/Equity | 0.66 | 2.85 | 1.35 | -5.14 | 0.48 | |||
| Current Ratio | 1.80 | 2.01 | 1.57 | 1.60 | 2.69 | |||
| Return On Assets (ROA) | -10.23% | -19.48% | -11.95% | -37.72% | -31.03% | |||
| Return On Equity (ROE) | -28.60% | -158.03% | -47.79% | N/A | -113.54% | |||
All data in USD